American Journal of Cardiology
Volume 103, Issue 12 , Pages 1663-1671, 15 June 2009

Two-Year Results of Paclitaxel-Eluting Stents in Patients With Medically Treated Diabetes Mellitus from the TAXUS ARRIVE Program

  • John M. Lasala, MD, PhD

      Affiliations

    • Washington University School of Medicine, St. Louis, Missouri
    • ,
  • David A. Cox, MD

      Affiliations

    • Lehigh Valley Hospital, Allentown, Pennsylvania
    • ,
  • D. Lynn Morris, MD

      Affiliations

    • Albert Einstein Medical Center, Philadelphia, Pennsylvania
    • ,
  • Jeffrey A. Breall, MD, PhD

      Affiliations

    • Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, Indiana
    • ,
  • Paul D. Mahoney, MD

      Affiliations

    • Sentara Norfolk General Hospital, Norfolk, Virginia
    • ,
  • Phillip A. Horwitz, MD

      Affiliations

    • University of Iowa, Carver College of Medicine, Iowa City, Iowa
    • ,
  • Dinesh Shaw, MD

      Affiliations

    • Christus St. Frances Cabrini Hospital, Alexandria, Louisiana
    • ,
  • Kristin L. Hood, PhD

      Affiliations

    • Boston Scientific Corporation, Marlborough, Massachusetts
    • Corresponding Author InformationCorresponding author: Tel: 508-683-6662; fax: 508-683-5642
    • ,
  • Lazar Mandinov, MD, PhD

      Affiliations

    • Boston Scientific Corporation, Marlborough, Massachusetts
    • ,
  • Keith D. Dawkins, MD

      Affiliations

    • Boston Scientific Corporation, Marlborough, Massachusetts

Received 7 January 2009; received in revised form 5 February 2009; accepted 5 February 2009. published online 20 April 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The ARRIVE 1 and ARRIVE 2 registries and this analysis were sponsored and funded by Boston Scientific Corporation, Natick, Massachusetts. Dr. Breall, Dr. Shaw, and Dr. Horwitz received grant support from Boston Scientific Corporation. Dr. Lasala, Dr. Cox, Dr. Morris, and Dr. Mahoney receive consulting fees from or serve on the advisory board to Boston Scientific Corporation. Dr. Hood, Dr. Dawkins, and Dr. Mandinov are full-time employees of Boston Scientific Corporation and have stock options or equity interest in Boston Scientific Corporation.

PII: S0002-9149(09)00590-6

doi:10.1016/j.amjcard.2009.02.035

American Journal of Cardiology
Volume 103, Issue 12 , Pages 1663-1671, 15 June 2009

Article Tools

* Image Usage & Resolution